Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice

Peptides

Volumn 17, Issue 8, 1996, Pages 1415-1419

  Bian, Jing Tan ^a   Bhargava, Hemendra N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

D Ala2,Glu4 Deltorphin II; D Pen2,D Pen5 Enkephalin; antinociception; Mice; Morphine; Multiple opioid receptor agonists; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; MORPHINE 3 GLUCURONIDE; OPIATE AGONIST; OPIATE RECEPTOR; PEPTIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; NOCICEPTORS; OLIGOPEPTIDES; PYRROLIDINES; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0030458198     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00215-X     Document Type: Article

References (30)

1. 1. Barjavel, M. J.; Sandouk, P.; Plotkine, M.; Scherrmann, J. M. Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis. Life Sci. 55:1301-1308; 1994.
2. 2. Barjavel, M. J.; Scherrmann, J. M.; Bhargava, H. N. Relationship between morphine analgesia and cortical extra-cellular fluid levels of morphine and its metabolites in the rat: A microdialysis study. Br. J. Pharmacol. 116:3205-3210; 1995.
3. 3. Beitz, A. J.; Larson, A. A. Inhibition of intrathecally administered picrotoxin and bicuculline-induced convulsions in mice by pipecolic acid or GABA. Eur. J. Pharmacol. 114:181-187; 1985.
4. 4. Bhargava, H. N.; Thorat, S. N. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonist in the mouse. Brain Res. 649:111-116; 1994.
5. 5. Carrupt, P. A.; Testa, B.; Bechanlany, A.; EL Tayar, N.; Descas, P.; Perissoud, D. Morphine-6-glucuronide and morphine-3-glucuronide as molecular chameleons with unexpected lipophilicity. J. Med. Chem. 34:1272-1275; 1991.
6. 6. Coughtrie, M. W. H.; Ask, B.; Rane, A.; Burchell, B.; Hume, R. The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme. Biochem. Pharmacol. 38:3273-3280; 1989.
7. 7. D'Amour, F. E.; Smith, D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:74-79; 1941.
8. 8. Ekblom, M.; Gardmark, M.; Hammarlund-Udenales, M. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinocieceptive effect of morphine. Biopharm. Drug Dispos. 14:1-11; 1993.
9. 9. Frances, B.; Gout, R.; Monsarrat, B.; Cros, J.; Zajac, J. M. Further evidence that morphine-6-β-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 262:25-31; 1992.
10. 10. Game, C. J. A.; Lodge, D. The pharmacology of the inhibition of dorsal horn neurones by impulses in myelinated cutaneous afferents in the cat. Exp. Brain Res. 23:75-84; 1975.
11. 11. Gong, Q.-L.; Hedner, T.; Mender J.; Bjorkman, R.; Noremberg, G. Antinociceptive and ventilatory effect of the morphine metabolites: Morphine-6-glucuronide and morphine-3-glucuronide. Eur. J. Pharmacol. 193:47-56; 1991.
12. 12. Gong, Q.-L.; Hedner, J.; Bjorkman, R.; Hedner, T. Morphine 3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 48:249-255; 1992.
13. 13. Haley, T. J.; McCormick, W. G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12:12-15; 1957.
14. 14. Hanna, M. H.; Peat, S. J.; Woodham, A.; Knibb, A.; Fung, C. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: Comparison with morphine. Br. J. Anesth. 64:547-550; 1990.
15. 15. Kuo, C. K.; Hanioka, N.; Hoshikawa, Y.; Oguri, K.; Yoshimura, H. Species difference of site-selective glucuronidation of morphine. J. Pharmacobiodyn. 14:187-193; 1991.
16. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:583-587; 1991.
17. 17. Osborne, R. J.; Joel, S. P.; Trew, D.; Slevin, M. L. Analgesic activity of morphine-6-glucuronide. Lancet I: 828; 1988.
18. 18. Pacifi, G. M.; Rane, A. Renal glucuronidation of morphine in human fetus. Br. J. Clin. Pharmacol. 13:732-735; 1982.
19. 19. Pasternak, G. W.; Bodnar, R. J.; Clark, J. A.; Inturrisi, C. E. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41:2845-2849; 1987.
20. 20. Shimomura, K.; Kamara, O.; Ueki, S.; Ida, S.; Oguri, K.; Yoshimura, H.; Tsukamoto, H. Analgesic effect of morphine glucuronides. J. Exp. Med. 105:45-52; 1971.
21. 21. Smith, M. T.; Watt, J. A.; Cramond, T. Morphine-3-glucuronide: A potent antagonist of morphine analgesia. Life Sci. 47:579-585; 1990.
22. 22. Stain, F.; Barjavel, M. J.; Sandouk, P.; Plotkine, M.; Scherrmann, J. M.; Bhargava, H. N. Analgesic responses and plasma and extra cellular fluid pharmacokinetics of morphine and morphine-6-glucuronide in the rat. J. Pharmacol. Exp. Ther. 274:852-857; 1995.
23. 23. Sullivan, A. F.; McQuay, H. J.; Bailay, D.; Dickenson, A. H. The spinal antinociceptive actions of morphine metabolites, morphine-6-glucuronide and normorphine in the rat. Brain Res. 482:219-224; 1989.
24. 24. Wahlstrom, A.; Lunding, B.; Ask, B.; Rane, A. The sensitivity to noxious heat in relation to brain and liver opioid glucuronidation inbred strains of mice. Pain 38:71-75; 1989.
25. 25. Wahlstrom, A.; Winblad, B.; Bixo, M.; Rane, A. Human brain metabolism of morphine and naloxone. Pain 35:121-127; 1988.
26. 26. Yeh, S. Y.; Gorodetzky, C. W.; Krebs, H. A. Isolation and identification of morphine 3-and 6-glucuronides, morphine 3, 6-diglucuronide, morphine 3-ethereal sulfate, normorphine and normorphine-6-glucuronide as morphine metabolites in humans. J. Pharm. Sci. 66:1288-1293; 1977.
27. 27. Yaksh, T. L.; Harty, G. J. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J. Pharmacol. Exp. Ther. 244:501-507; 1988.
28. 28. Yaksh, T. L.; Hatry, G. J.; Onofrio, B. M. High doses of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications. Anesthesiology 64:590-597; 1986.
29. 29. Yoshimura, H.; Ida, S.; Oguri, K.; Tsukamoto, H. Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats. Biochem. Pharmacol. 22:1423-1430; 1973.
30. 1-opioid receptor agonist. Peptides 17:233-236; 1996.